Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CIDR: Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos

ABSTRACT: CIDR: Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos

PROVIDER: PRJNA1231610 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

CIDR: Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos

Project description:CIDR: Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos

| PRJNA1231609 | ENA

Genome-Wide Association Study of Early Childhood Caries: CIDR

Project description:Genome-Wide Association Study of Early Childhood Caries: CIDR

| PRJNA671298 | ENA

Genome-Wide Association Study of Early Childhood Caries: CIDR

Project description:Genome-Wide Association Study of Early Childhood Caries: CIDR

| PRJNA671299 | ENA

Proteogenomics of High hyperdiploid childhood acute lymphoblastic leukemia

Project description:Proteogenomic analysis and genomic profiling, RNA-sequencing, and mass spectrometry-based analysis of High hyperdiploid childhood acute lymphoblastic leukemia.

2019-02-25 | PXD010175 | Pride

Proteogenomics of High hyperdiploid childhood acute lymphoblastic leukemia

Project description:Proteogenomic analysis and genomic profiling, RNA-sequencing, and mass spectrometry-based analysis of High hyperdiploid childhood acute lymphoblastic leukemia.

2020-01-29 | MSV000084862 | MassIVE

Transcription profiling of B-cells stimulated by different compounds (CIDR GST anti Ig)

Project description:Transcription profiling of B-cells stimulated by different compunds (CIDR; GST; anti Ig)

2005-06-30 | E-MEXP-316 | biostudies-arrayexpress

Proteomics analysis of childhood acute lymphoblastic leukemia cell lines reveals novel drug vulnerabilities

Project description:Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and it has a 5-year survival rate of 85% for European children. But for subsets of patients who fail to respond to standard of care chemotherapeutics, treatment options are limited, and clinical prognosis is poor. To establish a platform and methodology to better characterize ALL subtypes and identify their pharmacologic vulnerabilities, we assembled a biobank of 49 readily available childhood ALL cell lines representing diverse immunotypes and genetic profiles. Using these cell lines, we performed comprehensive multi-omic analyses, providing proteomic, transcriptomic and pharmacoproteomic characterization of childhood ALL. We used this resource to characterize the functional impact of genetic fusions and cellular differentiation states on the proteome. Additionally, we identified a novel drug vulnerability in one of the ALL subtypes. Our results are provided as an interactive online data portal with navigable proteomics, transcriptomics, and drug sensitivity profiles.

2022-03-26 | PXD023662 | Pride

Transcriptome analysis of childhood acute lymphoblastic leukemia cell lines

Project description:Transcriptome profiling of 49 childhood acute lymphoblastic leukemia cell lines and 2 EBV transformed B-cell lines.

2022-02-16 | GSE168386 | GEO

circRNA expression in relapsed childhood acute lymphoblastic leukemia

Project description:3 patients with childhood acute lymphoblastic leukemia were diagnosed with relapsed, and the matched new diagnosed blood samples were enrolled as controls. CirRNA array were conducted for detecting the expression of miRNA in above samples.

2025-03-01 | E-MTAB-13177 | biostudies-arrayexpress

miRNA expression in relapsed childhood acute lymphoblastic leukemia

Project description:3 patients with childhood acute lymphoblastic leukemia were diagnosed with relapsed, and the matched new diagnosed blood samples were enrolled as controls. MiRNA array were conducted for detecting the expression of miRNA in above samples.

2025-03-01 | E-MTAB-13176 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data